FDA introduces “Future Framework” for re-coding mRNA vaccines, no need for trials!

The FDA’s advisory group VRBPAC discussed the “Future Framework” for the first time on April 6, 2022.  “All of the committee members agreed that COVID-19 shots are not working, that boosting multiple times a year was not feasible, and that the shots need to be reformulated. They also unanimously agreed that there are no “correlates of protection” that one can use to predict what antibody levels would be sufficient to prevent SARS-CoV-2 infection.”

The “Future Framework” is a plan to rig the Covid-19 vaccine regulatory process in perpetuity with the so-called “next generation” COVID-19 shots.

The urgency of this matter was pushed because vaccine manufactures wanted a vaccine strain selection by June 2022 in order to deliver shots for autumn supply.

On June 28, 2022, VRBPAC met and voted to move forward with boosters formulated with Wuhan and Omicron variants even though there is little data. [2]